Gabriela Monroy

MD. PYG-4 Urology 🇨🇴 @medicinapuj @urologiaPUJ

[Andrés Forero CD @AForeroM]

@petrogustavo Petro es un mal perdedor, un mentiroso y un irresponsable.

El preconteo habla de una diferencia cercana al 1% con el 99,58% de las mesas informadas.

Afortunadamente el 7 de agosto se acaba la horrible noche.

[Laura Bukavina @LauraBukavinaMD]

One is not like the others … 🫤 …2026

[Paloma Valencia L @PalomaValenciaL]

Mientras la gente se muere, el gobierno nombra como superintendente de salud a Daniel Quintero, que tiene 43 miembros de su alcaldía imputados. Es un insulto a los colombianos.

[Gabriela Monroy @gabmonroy1]

Right renal mass with grade II tumor thrombus in IVC. Amazing case with out vascular surgery team.

#urosome #urology #urologiconcology

[David Luna @lunadavid]

Siempre hay un trino.

[European Urology @EUplatinum]

Spotlight: Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors by Alessandro Larcher et al

#Spotlight #Medtwitter #UroSoMe #RenalCancer

[NEJM @NEJM]

At 23 years of follow-up, population-based PSA screening of asymptomatic men led to a sustained reduction in prostate cancer mortality, although overdiagnosis remains a concern. Full ERSPC study results: https://t.co/iwULrhSglD

Editorial: Early Detection of Prostate Cancer — Time to Fish or Cut Bait https://t.co/G9Kmvrqrzj

[European Urology @EUplatinum]

🚨 New in European Urology:
Consolidative surgery after #EnfortumabVedotin +/– ICI in advanced urothelial carcinoma:
✅ 82% downstaging
✅ 43% ypT0N0
✅ 79% stopped systemic therapy
✅ 89% DFS in curative group

📄 https://t.co/Yd52YZKRNk
#BladderCancer #Immunotherapy #Urology

[UroToday.com @urotoday]

Nadofaragene firadenovec: Efficacy, dosing, and real-world performance in BCG-unresponsive #NMIBC. @AlbertoMartini_ @CincyUrology joins @UroDocAsh @MDAndersonNews to discuss treatment sequencing in BCG-unresponsive non-muscle invasive #BladderCancer. #WatchNow > https://t.co/p6QuizoeGK

[UroToday.com @urotoday]

Intravesical antibody drug Conjugates for #BladderCancer. @DiMariaJiang @pmcancercentre sits down with @UroDocAsh @MDAndersonNews to discuss how ADCs are transforming bladder cancer care and reshaping 1L treatment, boosting neoadjuvant response rates & even sparking bladder preservation conversations. A "golden era" in progress! #WatchNow > https://t.co/QfLzH8Hgl5 💥

[Laura Bukavina @LauraBukavinaMD]

New data on hydro TMT in MIBC 🚨guess that’s why it’s not ideal 👎
📊 74% of patients with pre-existing hydronephrosis still had it post-TMT
💧 21% of patients WITHOUT hydronephrosis developed it after TMT
🧵 52% of new cases needed PCNT drainage…. https://t.co/0URFvayrCQ
#BladderCancer

[JAMA Oncology @JAMAOnc]

Viewpoint: Prostate cancer screening is shifting toward a more beneficial and less harmful approach by using MRI-targeted strategies, which reduce unnecessary biopsies and overdiagnosis. https://t.co/FsfSs3xmkG @IvoSchootsNL

[Alejandro Gaviria @agaviriau]

Un mensaje indolente, sin sentido, indigno de un presidente o de cualquier líder político. Produce rabia y desazón.

https://t.co/VocvwA46gV

[UroToday.com @urotoday]

How to crush a PSMA PET report: guidelines and scoring systems Dr. Phillip Kuo @cityofhope. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/zHf36kQMUR @PCFnews @PSMAconference #PSMAandBeyond2025

[JAMA @JAMA_current]

Micro-ultrasonography-guided biopsy is noninferior to MRI-guided fusion biopsy for the detection of clinically significant prostate cancer in biopsy naïve men. https://t.co/QrWGbyHngl #EAU25 @JulianStruck @moisessocarras @ChrisFungMD @arvinkgeorge @TxetxuPereira

[Enrique Grande @drenriquegrande]

⚡️ Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy - Beyond the Abstract

#BladderCancer @urotoday

https://t.co/k8ZRW3TTAe

[UroToday.com @urotoday]

PSA dynamics from the phase 3 #EMBARK trial: A post hoc analysis. Presentation by Paul Sieber, MD. #SESAUA25 written coverage by @zklaassen_md > https://t.co/aDVmMKeu3H @SES_AUA

[Ricardo R Gonzalez MD @RRGonzalezMD]

The urology workforce shortage is real. It affects access to care everywhere, particularly in rural areas. We need to continue to adapt and implement strategies to retain and grow #urology @AmerUrological @urogoldjournal

[Gabriela Monroy @gabmonroy1]

Couple of days in pediatric urology
#urosome #urology #residency

[ASCO @ASCO]

In our latest “Science in Seconds” Dr. @BradMcG04 discusses 2 abstracts findings from phase 3 TALAPRO-2 trial highlighting final OS w TALA + ENZA as 1st-line Tx: 1 for unselected pts w #mCRPC & 1 for pts w HRR-deficient mCRPC. #GU25 https://t.co/YDlKrx7jNv https://t.co/YrXDgjyhx4